Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Protein Synthesis Rates Regulate Tumor-Initiating Potential and Chemoresistance in Multiple Myeloma

Eun-Hee Park, PhD, Mehrnoosh Soori, PhD MSc, Qiuju Wang, MSc, Lukasz P. Gondek, MD PhD, William Matsui, MD, Christian B. Gocke, MD PhD

Blood (2017) 130 (Supplement 1): 4390.

https://doi.org/10.1182/blood.V130.Suppl_1.4390.4390

Published: 2017

Journal Articles

Inhibiting Oncogenic RAS in Multiple Myeloma By Targeting Scaffold-ERK Interactions

Christian B. Gocke, MD PhD, Qiuju Wang, MA, Ross McMillan, Vesselin Penchev, Julien Sage, PhD, Paul A Khavari, MD PhD, William Matsui, MD

Blood (2014) 124 (21): 2089.

https://doi.org/10.1182/blood.V124.21.2089.2089

Published: 2014

Journal Articles

Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo

Lukasz P Gondek, MD PhD, Yiting Lim, PhD, Hideki Makishima, MD PhD, Qiuju Wang, MA, Jaroslaw P. Maciejewski, MD PhD FACP, Peter D Aplan, MD, Amy E. DeZern, MD MHS, William Matsui, MD

Blood (2014) 124 (21): 528.

https://doi.org/10.1182/blood.V124.21.528.528

Published: 2014

Journal Articles

Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells

Toshihiko Tanno, Yiting Lim, Qiuju Wang, Marta Chesi, P. Leif Bergsagel, Geoff Matthews, Ricky W. Johnstone, Nilanjan Ghosh, Ivan Borrello, Carol Ann Huff, William Matsui

Blood (2014) 123 (5): 725–733.

https://doi.org/10.1182/blood-2013-08-524025

Published: 2014

Includes: Supplemental data

Journal Articles

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Blood (2012) 120 (9): 1877–1887.

https://doi.org/10.1182/blood-2011-12-396853

Published: 2012

Includes: Supplemental data

Journal Articles

The TGF- β Family Member Growth Differentiation Factor 15 (GDF15) Regulates the Self-Renewal of Multiple Myeloma Cancer Stem Cells

Toshihiko Tanno, DVM, PhD, Akil Merchant, MD, Jasmin R. Agarwal, MD, MSc, Qiuju Wang, MA, William Matsui, MD

Blood (2011) 118 (21): 2954.

https://doi.org/10.1182/blood.V118.21.2954.2954

Published: 2011

Journal Articles

Mantle cell lymphoma activation enhances bortezomib sensitivity

Sarah K. Brennan, Brooke Meade, Qiuju Wang, Akil A. Merchant, Jeanne Kowalski, William Matsui

Blood (2010) 116 (20): 4185–4191.

https://doi.org/10.1182/blood-2010-02-268375

Published: 2010

Journal Articles

Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors

Akil Merchant, Giselle Joseph, Qiuju Wang, Sarah Brennan, William Matsui

Blood (2010) 115 (12): 2391–2396.

https://doi.org/10.1182/blood-2009-09-241703

Published: 2010

Includes: Supplemental data

Journal Articles

Nrf2, a Critical Regulator of Oxidative Stress, Is Required for HSC Function and Cytokine Response.

Akil Merchant, MD, Anju Singh, PhD, Giselle Joseph, BS, Qiuju Wang, MA, Ping Zhang, PhD, Sarah Brennan, BS, Shyam Biswal, PhD, William Matsui, MD

Blood (2009) 114 (22): 1492.

https://doi.org/10.1182/blood.V114.22.1492.1492

Published: 2009

Journal Articles

Cancer Stem Cell Activity in Mantle Cell Lymphoma Is Inhibited by TLR9 Activation

Sarah Brennan, Bs, Brooke Meade, BA, Qiuju Wang, MA, George Weiner, MD, William Matsui, MD

Blood (2008) 112 (11): 884.

https://doi.org/10.1182/blood.V112.11.884.884

Published: 2008

Journal Articles

The multiple myeloma–associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity

Josh Lauring, Abde M. Abukhdeir, Hiroyuki Konishi, Joseph P. Garay, John P. Gustin, Qiuju Wang, Robert J. Arceci, William Matsui, Ben Ho Park

Blood (2008) 111 (2): 856–864.

https://doi.org/10.1182/blood-2007-05-088674

Published: 2008

Includes: Supplemental data

Journal Articles

The MMSET Gene Contributes to the Growth, Adhesion, and Tumorigencitiy of t(4;14) Multiple Myeloma Cells.

Josh Lauring, MD, PhD, Abde M. Abukhdeir, PhD, Hiroyuki Konishi, MD, PhD, Joseph P. Garay, M.S., John P. Gustin, B.S., Qiuju Wang, M.S., Robert J. Arceci, MD, PhD, William Matsui, MD, Ben H. Park, MD, PhD

Blood (2007) 110 (11): 2636.

https://doi.org/10.1182/blood.V110.11.2636.2636

Published: 2007

Journal Articles

Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.

Qiuju Wang, MS, Craig Peacock, PhD, Kortney Hensley, Sarah Brennan, Akil Merchant, MD, Evan Jones, Irwin Freed, Richard Ambinder, MD, Karen McGovern, Martin Tremblay, D. Neil Watkins, MD, PhD, William Matsui, MD

Blood (2007) 110 (11): 3582.

https://doi.org/10.1182/blood.V110.11.3582.3582

Published: 2007

Journal Articles

Cancer Stem Cell Targeting in Multiple Myeloma by GRN163L, a Novel and Potent Telomerase Inhibitor.

William Matsui, MD, Qiuju Wang, MS, Milada Vala, James P. Barber, Alan Meeker, PhD, Robert Tressler, PhD, Calvin Harley, PhD, Carol A. Huff, MD, B. Douglas Smith, MD, Richard J. Jones, MD

Blood (2006) 108 (11): 2540.

https://doi.org/10.1182/blood.V108.11.2540.2540

Published: 2006

Journal Articles

Multiple Myeloma Stem Cells and Plasma Cells Display Distinct Drug Sensitivities.

William Matsui, MD, Carol Ann Huff, MD, Qiuju Wang, MS, James P. Barber, B. Douglas Smith, MD, Richard J. Jones, MD

Blood (2004) 104 (11): 2476.

https://doi.org/10.1182/blood.V104.11.2476.2476

Published: 2004

Journal Articles

Characterization of clonogenic multiple myeloma cells

William Matsui, Carol Ann Huff, Qiuju Wang, Matthew T. Malehorn, James Barber, Yvette Tanhehco, B. Douglas Smith, Curt I. Civin, Richard J. Jones

Blood (2004) 103 (6): 2332–2336.

https://doi.org/10.1182/blood-2003-09-3064

Published: 2004

NARROW

Protein Synthesis Rates Regulate Tumor-Initiating Potential and Chemoresistance in Multiple Myeloma

Inhibiting Oncogenic RAS in Multiple Myeloma By Targeting Scaffold-ERK Interactions

Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo

Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

The TGF- β Family Member Growth Differentiation Factor 15 (GDF15) Regulates the Self-Renewal of Multiple Myeloma Cancer Stem Cells

Mantle cell lymphoma activation enhances bortezomib sensitivity

Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors

Nrf2, a Critical Regulator of Oxidative Stress, Is Required for HSC Function and Cytokine Response.

Cancer Stem Cell Activity in Mantle Cell Lymphoma Is Inhibited by TLR9 Activation

The multiple myeloma–associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity

The MMSET Gene Contributes to the Growth, Adhesion, and Tumorigencitiy of t(4;14) Multiple Myeloma Cells.

Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.

Cancer Stem Cell Targeting in Multiple Myeloma by GRN163L, a Novel and Potent Telomerase Inhibitor.

Multiple Myeloma Stem Cells and Plasma Cells Display Distinct Drug Sensitivities.

Characterization of clonogenic multiple myeloma cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only